Evaluation of Efficacy and Safety of Galantamine in Subjects With Dementia of Alzheimer's Type Who Failed to Benefit From Donepezil.
Phase of Trial: Phase IV
Latest Information Update: 16 May 2014
At a glance
- Drugs Galantamine (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Janssen Pharmaceutical KK
- 01 Jun 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Dec 2012 Actual initiation date changed from Aug 2011 to Sep 2011 as reported by ClinicalTrials.gov.